Crystal Research Associates' Blog

Blog
About
Services
Research Library
In The Media
- Panel Discussions
Contact

Healthcare Conferences and News: Week of 1/9 to 1/13

Posted by Karen Goldfarb

January 13, 2012 at 11:20 AM

This has been a big week for healthcare and biotech.

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Date

May 2023 (2)
March 2023 (2)
January 2023 (1)
December 2022 (1)
November 2022 (1)
September 2022 (1)
August 2022 (2)
June 2022 (1)
May 2022 (1)
April 2022 (1)
March 2022 (2)
January 2022 (1)
November 2021 (2)
October 2021 (1)
August 2021 (1)
May 2021 (1)
March 2021 (1)
February 2021 (1)
December 2020 (1)
November 2020 (1)
October 2020 (1)
July 2020 (1)
June 2020 (1)
April 2020 (1)
March 2020 (1)
July 2019 (1)
May 2019 (1)
March 2019 (1)
February 2019 (1)
January 2019 (2)
December 2018 (1)
November 2018 (1)
October 2018 (2)
September 2018 (1)
August 2018 (2)
July 2018 (2)
March 2018 (1)
November 2017 (2)
October 2017 (1)
July 2017 (2)
June 2017 (1)
May 2017 (1)
April 2017 (1)
March 2017 (1)
February 2017 (1)
January 2017 (1)
December 2016 (1)
November 2016 (3)
September 2016 (3)
August 2016 (1)
July 2016 (1)
June 2016 (2)
May 2016 (2)
April 2016 (2)
January 2016 (2)
November 2015 (2)
October 2015 (1)
September 2015 (3)
August 2015 (1)
July 2015 (1)
June 2015 (3)
May 2015 (3)
April 2015 (2)
March 2015 (2)
February 2015 (2)
January 2015 (2)
December 2014 (4)
November 2014 (7)
October 2014 (11)
September 2014 (10)
August 2014 (5)
June 2014 (4)
May 2014 (3)
April 2014 (3)
March 2014 (2)
February 2014 (2)
January 2014 (5)
December 2013 (5)
November 2013 (5)
October 2013 (8)
September 2013 (2)
August 2013 (6)
July 2013 (1)
June 2013 (4)
May 2013 (5)
April 2013 (3)
February 2013 (2)
January 2013 (5)
December 2012 (1)
October 2012 (6)
September 2012 (3)
August 2012 (6)
July 2012 (3)
June 2012 (4)
May 2012 (9)
April 2012 (2)
March 2012 (4)
February 2012 (3)
January 2012 (8)
November 2011 (2)
October 2011 (1)
August 2011 (1)
July 2011 (1)
June 2011 (3)
May 2011 (2)
April 2011 (2)
March 2011 (2)
February 2011 (4)
January 2011 (4)
December 2010 (4)
November 2010 (4)
October 2010 (7)

see all

Posts by Topic

Crystal Research Associates (45)
Newsworthy Events (30)
immunotherapy (30)
New Research (29)
geovax (26)
hemorragic fever (25)
malaria (25)
vaccines (25)
aids/hiv (19)
hbv (19)
zika (19)
covid19 (18)
coronovirus (16)
AtheroNova (14)
BTHE (14)
biotech (14)
AEZS (13)
Pressure BioSciences (13)
nanotechnology (12)
Amarantus (10)
cancer (10)
LRAD (9)
OneMedForum (9)
green infrastructure (9)
CardioComm Solutions (8)
Truett-Hurst (8)
built environment (8)
CEL-SCI (7)
ISCO (7)
Applied DNA Sciences (6)
MetaStat (6)
biopharmaceuticals (6)
covid-19 (6)
lassa (6)
lasv (6)
Army Research Lab (5)
Bioniche (5)
CRRVF-OTCQB (5)
CVM-TSX (5)
Canon U.S.A. (5)
Carotid Stenotic Scan (CSS) (5)
Cleveland Clinic (5)
ENTICES Study (5)
Henry Ford Hospital (5)
Neonode Inc. (5)
Saleen (5)
Thomas Jefferson University Hospital (5)
Unilife Corp. (5)
atherosclerosis (5)
carotid health (5)
catasys (5)
cerebral angiogram (5)
computed tomography angiography (CTA) (5)
cvr medical (5)
duplex Doppler ultrasound (DUS) (5)
ischemic stroke (5)
magnetic resonance angiography (MRA) (5)
medical technology company (5)
occlusion (5)
stenosis (5)
stroke (5)
transient ischemic attack (TIA) (5)
Advaxis (4)
T3 Motion (4)
monkeypox (4)
Authentidate (3)
Biosceptre (3)
GenSpera (3)
MedPro (3)
Neuralstem (3)
Pluristem Therapeutics (3)
Prefilled Syringe (3)
SARS-CoV-2 (3)
autoimmune (3)
biotechnology (3)
touch technology (3)
zForce (3)
AMBS (2)
Cannabis (2)
Document Capture Technologies (2)
Ebola (2)
Endocannabinoid System (ECS) (2)
FSD201 (2)
JUHL (2)
Local Corporation (2)
MS (2)
Macrilen (2)
Multikine (2)
Palmitolylethonalamide (PEA) (2)
Peregrine (2)
Ra Medical (2)
SpectraScience (2)
Targeted Therapies (2)
Trio Resources (2)
artificial intelligence (AI) (2)
bioxytran (2)
cervical dysplasia (2)
complex carbohydrate chemistry (2)
fsd (2)
fsd pharma (2)
galectin (2)
galectrin-3 (2)
glycovirology (2)
head and neck cancer (2)
human induced pluripotent stem cell (2)
infectious diseases (2)
inflammatory (2)
leaps (2)
medical cannabis (2)
multiple sclerosis (2)
neurodegenerative (2)
rheumatoid arthritis (2)
squamous cell carcinoma (2)
ultramicronized-PEA (2)
wordlogic predictive keyboard (2)
xbit (2)
ABC News (1)
ACT Biotech (1)
Adamis (1)
Al Jazeera (1)
Albany NanoTech Complex (1)
Antibody (1)
Aperion (1)
Augmented reality (1)
Aura Health Inc. (1)
Bellus Health (1)
Biologics (1)
BreastSentry (1)
Bridgelux (1)
C-Ion® (1)
COVID-19 testing (1)
CZO (1)
Cameco Corp (1)
Canntab Therapeutics Ltd (1)
Carbon-Ion™ (1)
Clarity Lab Solutions (1)
College of Nanoscale Science and Engineering (1)
ColonSentry (1)
Commercial Solutions of Insurance Agency (1)
Contract manufacturing organization (CMO) (1)
Contract research organization (CRO) (1)
Convoy Therapeutics (1)
Craig Dionne (1)
Creator Economy (1)
Customer relationship management (CRM) (1)
D-CHIP™ (1)
EMMA (1)
EarlyCDT®-Lung (1)
Electronic medical records (1)
Employee Benefit Solutions (1)
Enterprise resource planning (ERP) (1)
Equinox (1)
ExpressMD (1)
Fortman Insurance Agency (1)
Fourth Industrial Revolution (1)
GEN-1 (1)
GLG Pharma (1)
Gen 4 technology (1)
General Cannabis (1)
Geomega (1)
GreenSteel (1)
Gunnar Weikert (1)
HEB (1)
Helomics® Corporation (1)
Huge Shops (1)
Human monoclonal antibodies (1)
Humanized monoclonal antibodies (1)
Huntingtons Disease (1)
IL-12 (1)
IR App (1)
Immunoassay (1)
Immunogen (1)
Inscrybe (1)
Internet of Things (1)
James Hayward (1)
KIACTA (1)
L-glutamine (1)
Lacoste (1)
Leslie Ziegler (1)
MNGA (1)
MZ Group (1)
Marburg (1)
Mark Reddish (1)
Metaverse (1)
Monoclonal antibody (1)
NBA (1)
NVIV (1)
New York Senate Higher Education Committee (1)
Non-fungible tokens (1)
Novo Nordisk (1)
Oncology (1)
PPHM (1)
Parkinsons Disease (1)
Pharmascience (1)
Polyclonal antibody (1)
Prismic Pharmaceuticals (1)
Prostate Cancer (1)
Puget Sound Blood Center (1)
Puma (1)
REIT (1)
RELI (1)
Rare earth elements (1)
Reuters (1)
SG Blocks (1)
SGBX (1)
SSc (1)
STREAMWAY System (1)
Saas (1)
Sanitec (1)
SciCann Therapeutics (1)
SearchCore (1)
Sentinel Principle (1)
Skyline Medical (1)
Software-as-a-Service (1)
Soladigm (1)
Solar photovoltaic (1)
Solarvest BioEnergy Inc. (1)
Southwestern Montana Insurance Center (1)
StageZero Life Sciences (1)
Starbucks (1)
Sudan (1)
Synthetic Biologics (1)
Taco Bell (1)
TapImmune (1)
Tauriga (1)
The Referral Depot (1)
The Steve Harvey Show (1)
ThermoDox (1)
TumorGenesis (1)
U.S. Benefits Alliance (1)
Unicorn company (1)
University of Albany (1)
VIVIMIND (1)
Verizon (1)
Victory Square Technologies (1)
Virtual reality (1)
Web 3.0 (1)
Xbiotech (1)
Zap&Go (1)
ZapGo Ltd (1)
aipt (1)
batteries (1)
bioinformatics (1)
bipilar disorder (1)
blood-based diagnostics (1)
breast cancer (1)
cancer vaccine (1)
cannabidiol (1)
cannabigerol (1)
cannabinoids (1)
cargo modified modules (1)
celsion (1)
clean technology metals (1)
color logic (1)
cordless power tools (1)
diabetes (1)
digitalDNA™ (1)
diverticulosis (1)
eletric cars (1)
emmaus life sciences (1)
endari (1)
energy storage device (1)
enterprise software (1)
fibrotic (1)
gene therapy (1)
generic drugs (1)
genomic (1)
genprex (1)
global graphics (1)
green building (1)
green construction (1)
hardware (1)
hepatocellular cancer (1)
hpv (1)
hybrid software (1)
hybrid software group (1)
hysg (1)
ic3d (1)
infrared touchscreen (1)
inkjet printing (1)
insurance (1)
insurance agencies (1)
insurance carriers (1)
interleukin-12 (1)
junior mining (1)
laptop computers (1)
liquid biopsy (1)
magnegas (1)
major depressive disorder (MDD) (1)
medical fluid waste collection (1)
mineral exploration (1)
mobile phones (1)
modular construction (1)
multi-family properties (1)
myelin degradation (1)
non-small cell lung cancer (1)
original equipment manufacturers (1)
orphan diseases (1)
orphan drug (1)
ovarian cancer (1)
personalized medicine (1)
precision medicine (1)
precision oncology (1)
precision therapeutics (1)
primary liver cancer (1)
proprietary Gen 3 technology (1)
real estate (1)
reliance global group (1)
reliance global holdings (1)
shipping containers (1)
sickle cell crisis (1)
sickle cell disease (1)
small-cell lung cancer (1)
systemic sclerosis (1)
technology (1)
telemedicine (1)
 REQORSA (1)

FIND US ONLINE

CONTACT INFORMATION

Phone: (212) 851-6685

Disclaimers